DLCO biological controls in clinical practice.

G. Roque Guerin (Barcelona, Spain), M. Palomo (Barcelona, Spain), M. Medina (Barcelona, Spain), J. Moises (Barcelona, Spain), F. Burgos (Barcelona, Spain)

Source: International Congress 2019 – Quality, performance and interpretation of lung function testing
Session: Quality, performance and interpretation of lung function testing
Session type: Thematic Poster
Number: 1132
Disease area: -

Congress or journal article abstract

Rating: 5
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. Roque Guerin (Barcelona, Spain), M. Palomo (Barcelona, Spain), M. Medina (Barcelona, Spain), J. Moises (Barcelona, Spain), F. Burgos (Barcelona, Spain). DLCO biological controls in clinical practice.. 1132

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
A correlative analysis between spirometry and MostGraph using the 23306 data from 3979 patients in clinical practice.
Source: International Congress 2018 – Clinical and functional monitoring in airway disease
Year: 2018

DLco simulations for qualification of DLco devices globally for inhaled levodopa clinical trials.
Source: International Congress 2019 – Quality, performance and interpretation of lung function testing
Year: 2019


Interpreting lung function in clinical practice
Source: Annual Congress 2006 - PG5 - Respiratory physiology: interpreting lung function in health and disease
Year: 2006

Pattern of diffusion disturbance related to clinical diagnosis: the KCO has no additional diagnostic value next to the DLCO
Source: Eur Respir J 2005; 26: Suppl. 49, 523s
Year: 2005

Reducing the variability of DLCO measurements in clinical trials
Source: International Congress 2019 – Physiologic assessment of airway diseases
Year: 2019


Comparison of sputum characteristics with clinical, laboratorial and functional variables in patients with stable COPD
Source: Annual Congress 2010 - Colonisation and infection in COPD
Year: 2010

The better explanation of COPD: the clinical role of FVC grouping
Source: International Congress 2019 – Physiologic assessment of airway diseases
Year: 2019

A critical evaluation of the relevance of different asthma phenotypes for clinical practice
Source: Annual Congress 2008 - A step-change in asthma. The Lancet/ERS symposium
Year: 2008


Correlations of ventilation heterogeneity and spirometry in asthma; initial experience with hyperpolarised gas MRI in a clinical setting.
Source: International Congress 2019 – Imaging in respiratory disease: novel technologies in 2019
Year: 2019


An international survey on genetics in clinical practice for interstitial lung disease.
Source: Virtual Congress 2021 – Exercise tolerance, supportive care and more in non-pulmonary fibrosis interstitial lung diseases
Year: 2021


Association of demographic, laboratory and clinical parameters with HRCT-chest findings in patients with sarcoidosis.
Source: International Congress 2019 – Sarcoidosis: a multifaceted disease that is difficult to manage
Year: 2019

COPD management in Swedish clinical practice
Source: Annual Congress 2007 - Primary care management of COPD
Year: 2007


Assessment of disease control in smokers and non-smokers with asthma in Switzerland: results of an experience-based report in medical practice
Source: Annual Congress 2006 - Smoking asthmatics – a neglected population?
Year: 2006


The clinical usefulness of spirometric information
Source: Breathe 2008; 5: 214-220
Year: 2009

ArtiQ.QC facilitates spirometry quality control in asthma and COPD clinical trials
Source: Virtual Congress 2021 – Future advances in respiratory physiology
Year: 2021


Distribution of COPD phenotypes according to the Spanish COPD guidelines in clinical practice
Source: International Congress 2015 – Notable abstracts in COPD: variety
Year: 2015



The effects of standard therapy for COPD patients on FEV1 are associated with lower score of the Goddard classification
Source: International Congress 2014 – Multidimensional analysis of respiratory problems
Year: 2014


Percent predicted forced vital capacity (FVC) is a reliable, valid, and responsive measure of clinical status in patients with idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2010 - Clinical issues in idiopathic pulmonary fibrosis
Year: 2010

FEV6: a useful outcome measure of lung function in COPD as assessed in a large clinical study with roflumilast
Source: Eur Respir J 2004; 24: Suppl. 48, 342s
Year: 2004